Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants

Journal of Pediatrics

Volumn 175, Issue , 2016, Pages 68-73.e3

  Sherman, Michael P ^a   Adamkin, David H ^b   Niklas, Victoria ^c   Radmacher, Paula ^b   Sherman, Jan ^a,d   Wertheimer, Fiona ^c   Petrak, Karel ^e  

^a University of Missouri   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e AGENNIX INC   (United States)

Author keywords

hospital acquired infection; lactoferrin; safety; VLBW infant

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; C REACTIVE PROTEIN; PLACEBO; TALACTOFERRIN; LACTOFERRIN; PROTECTIVE AGENT;

ANTIBIOTIC THERAPY; BIRTH WEIGHT; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HOSPITAL INFECTION; HUMAN; INFANT; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; METABOLIC DISORDER; NECROTIZING ENTEROCOLITIS; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; BACTEREMIA; CROSS INFECTION; ENTEROCOLITIS, NECROTIZING; FOLLOW UP; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; INFANT, PREMATURE, DISEASES; NEWBORN; ORAL DRUG ADMINISTRATION; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

ADMINISTRATION, ORAL; BACTEREMIA; CROSS INFECTION; DOUBLE-BLIND METHOD; ENTEROCOLITIS, NECROTIZING; FEMALE; FOLLOW-UP STUDIES; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LACTOFERRIN; MALE; MENINGITIS; PNEUMONIA; PROTECTIVE AGENTS; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 84973632318     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.04.084     Document Type: Conference Paper

References (22)

1. 1 Polin, R.A., Denson, S., Brady, M.T., Epidemiology and diagnosis of health care-associated infections in the NICU. Pediatrics 129 (2012), e1104–e1109.
2. 2 Bizzarro, M.J., Shabanova, V., Baltimore, R.S., Dembry, L.M., Ehrenkranz, R.A., Gallagher, P.G., Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci. J Pediatr 166 (2015), 1193–1199.
3. 3 Polin, R.A., Denson, S., Brady, M.T., Strategies for prevention of health care-associated infections in the NICU. Pediatrics 129 (2012), e1085–e1093.
4. 4 Cantey, J.B., Milstone, A.M., Bloodstream infections: epidemiology and resistance. Clin Perinatol 42 (2015), 1–16.
5. 5 Collado, M.C., Cernada, M., Neu, J., Pérez-Martínez, G., Gormaz, M., Vento, M., Factors influencing gastrointestinal tract and microbiota immune interaction in preterm infants. Pediatr Res 77 (2015), 726–731.
6. 6 Patel, A.L., Johnson, T.J., Engstrom, J.L., Fogg, L.F., Jegier, B.J., Bigger, H.R., et al. Impact of early human milk on sepsis and health-care costs in very low birth weight infants. J Perinatol 33 (2013), 514–519.
7. 7 Sullivan, S., Schanler, R.J., Kim, J.H., Patel, A.L., Trawöger, R., Kiechl-Kohlendorfer, U., et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 156 (2010), 562–567.e1.
8. 8 Neu, J., Mihatsch, W.A., Zegarra, J., Supapannachart, S., Ding, Z.Y., Murguía-Peniche, T., Intestinal mucosal defense system, Part 1. Consensus recommendations for immunonutrients. J Pediatr 162:3 Suppl (2013), S56–S63.
9. 9 Sherman, M.P., Adamkin, D.H., Radmacher, P.G., Sherman, J., Niklas, V., Protective proteins in mammalian milks: lactoferrin steps forward. Neoreviews 13 (2012), e293–e300.
10. 10 Jiang, R., Du, X., Lönnerdal, B., Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk. J Pediatr Gastroenterol Nutr 59 (2014), 642–652.
11. 11 Ward, P.P., Piddington, C.S., Cunningham, G.A., Zhou, X., Wyatt, R.D., Conneely, O.M., A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology (N Y) 13 (1995), 498–503.
12. 12 Edde, L., Hipolito, R.B., Hwang, F.F., Headon, D.R., Shalwitz, R.A., Sherman, M.P., Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 281 (2001), G1140–G1150.
13. 13 McKibben, L., Horan, T.C., Tokars, J.I., Fowler, G., Cardo, D.M., Pearson, M.L., et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 26 (2005), 580–587.
14. 14 Walsh, M.C., Kliegman, R.M., Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33 (1986), 179–201.
15. 15 Brajovic S. MedDRA use at FDA. http://www.ich.org/fileadmin/Public_Web_Site/Training/GCG-_Endorsed_Training_Events/ASEAN_MedDRA_March_2010/Day_3/Regulatory_Perspective_SBrajovic.pdf. Accessed April 26, 2016.
16. 16 Weiss LG, Oakland T, Aylward GP, Eds. Bayley III. Clinical use and interpretation. Burlington, MA: Elsevier Inc.; 2010.
17. 17 Manzoni, P., Rinaldi, M., Cattani, S., Pugni, L., Romeo, M.G., Messner, H., et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 302 (2009), 1421–1428.
18. 18 Manzoni, P., Meyer, M., Stolfi, I., Rinaldi, M., Cattani, S., Pugni, L., et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 90:Suppl 1 (2014), S60–S65.
19. 19 Akin, I.M., Atasay, B., Dogu, F., Okulu, E., Arsan, S., Karatas, H.D., et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am J Perinatol 31 (2014), 1111–1120.
20. 20 Ochoa, T.J., Zegarra, J., Cam, L., Llanos, R., Pezo, A., Cruz, K., et al. Randomized controlled trial of lactoferrin for prevention of sepsis in Peruvian neonates less than 2500 g. Pediatr Infect Dis J 34 (2015), 571–576.
21. 21 Pineda, L.C., Hornik, C.P., Seed, P.C., Cotten, C.M., Laughon, M.M., Bidegain, M., et al. Association between positive urine cultures and necrotizing enterocolitis in a large cohort of hospitalized infants. Early Hum Dev 91 (2015), 583–586.
22. 22 Sherman, M.P., Minnerly, J., Curtiss, W., Rangwala, S., Kelley, S.T., Research on neonatal microbiomes: what neonatologists need to know. Neonatology 105 (2014), 14–24.